Format

Send to

Choose Destination
Arthritis Rheumatol. 2019 Jan 21. doi: 10.1002/art.40816. [Epub ahead of print]

CCL21 is a potential biomarker in pulmonary arterial hypertension in Systemic Sclerosis: Reply to Xu et al.

Author information

1
Oslo University Hospital, Rheumatology, Oslo, Norway.

Abstract

We thank Xu and co-workers for their interest regarding our newly published article on the role of CCL21 in pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc) (1). Here, we want to respond to their concerns. This article is protected by copyright. All rights reserved.

PMID:
30663863
DOI:
10.1002/art.40816

Supplemental Content

Full text links

Icon for Wiley Icon for Norwegian BIBSYS system
Loading ...
Support Center